These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10953261)

  • 1. Hormone replacement therapy and cardiovascular risk.
    Gerhard-Herman M; Hamburg N; Ganz P
    Curr Cardiol Rep; 2000 Jul; 2(4):288-92. PubMed ID: 10953261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmenopausal women and cardiovascular risk: impact of hormone replacement therapy.
    Rosano GM; Fini M
    Cardiol Rev; 2002; 10(1):51-60. PubMed ID: 11790270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
    Grady D; Herrington D; Bittner V; Blumenthal R; Davidson M; Hlatky M; Hsia J; Hulley S; Herd A; Khan S; Newby LK; Waters D; Vittinghoff E; Wenger N;
    JAMA; 2002 Jul; 288(1):49-57. PubMed ID: 12090862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal hormone therapy: cardiovascular risks.
    Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study.
    Simon JA; Hunninghake DB; Agarwal SK; Lin F; Cauley JA; Ireland CC; Pickar JH
    Ann Intern Med; 2001 Oct; 135(7):493-501. PubMed ID: 11578152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen replacement therapy and the prevention of coronary heart disease in postmenopausal women.
    Contreras I; Parra D
    Am J Health Syst Pharm; 2000 Nov; 57(21):1963-8; quiz 1969-71. PubMed ID: 11094650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preserving cardiovascular benefits of hormone replacement therapy.
    Bush TL
    J Reprod Med; 2000 Mar; 45(3 Suppl):259-73. PubMed ID: 10756507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular pharmacology of hormone replacement therapy.
    Rosano GM; Panina G
    Drugs Aging; 1999 Sep; 15(3):219-34. PubMed ID: 10503814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen replacement and brachial artery flow-mediated vasodilation in older women.
    Herrington DM; Espeland MA; Crouse JR; Robertson J; Riley WA; McBurnie MA; Burke GL
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):1955-61. PubMed ID: 11742870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
    Hulley S; Furberg C; Barrett-Connor E; Cauley J; Grady D; Haskell W; Knopp R; Lowery M; Satterfield S; Schrott H; Vittinghoff E; Hunninghake D;
    JAMA; 2002 Jul; 288(1):58-66. PubMed ID: 12090863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM; Vitale C; Fini M
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective effects of ovarian hormones and the HERS in perspective.
    Rosano GM; Graziottin A; Fini M
    Maturitas; 2000 Apr; 34 Suppl 2():S3-10. PubMed ID: 10915917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HERS trial results: paradigms lost? Heart and Estrogen/progestin Replacement Study.
    Herrington DM
    Ann Intern Med; 1999 Sep; 131(6):463-6. PubMed ID: 10498564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
    Sammartino A; Cirillo D; Mandato VD; Di Carlo C; Nappi C
    J Endocrinol Invest; 2005; 28(10 Suppl):80-4. PubMed ID: 16550729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal hormone use for cardioprotection: what we know and what we must learn.
    Wenger NK
    Curr Opin Cardiol; 1999 Jul; 14(4):292-7. PubMed ID: 10448608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease.
    Grodstein F; Manson JE; Colditz GA; Willett WC; Speizer FE; Stampfer MJ
    Ann Intern Med; 2000 Dec; 133(12):933-41. PubMed ID: 11119394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.
    Nabulsi AA; Folsom AR; White A; Patsch W; Heiss G; Wu KK; Szklo M
    N Engl J Med; 1993 Apr; 328(15):1069-75. PubMed ID: 8384316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Estrogens for prevention of coronary heart disease?].
    Meinertz T
    Herz; 1997 Jun; 22(3):151-7. PubMed ID: 9303898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.